Pseudo-Zellweger syndrome: Clinical Trials

3 trials for Pseudo-Zellweger syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1
Phase 21Active not recruiting 1

Follow Pseudo-Zellweger syndrome: new trials by email Literature Review of Pseudo-Zellweger syndrome trials Research Report on Pseudo-Zellweger syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Stem Cell Transplantation, IMD Preparative Regimen, Osteopetrosis Only Preparative Regimen - Mucopolysaccharidosis Disorders, Hurler Syndrome
Phase 2Active not recruitingMasonic Cancer Center, University of Minnesota1492014-07-102026-01-07
Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)
Peroxisome Biogenesis Disorder, Zellweger Spectrum Disorder
RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre2442012-01-012026-10-13
Study of Bile Acids in Patients With Peroxisomal Disorders
chenodeoxycholic acid, cholic acid, ursodiol - Infantile Refsum's Disease, Zellweger Syndrome
Not applicableTerminatedUniversity of Cincinnati252015-03-25

Narrower conditions

Zellweger Syndrome (3)  ·  Alpha-Methylacyl-CoA Racemase Deficiency (2)  ·  Peroxisomal ACYL-COA oxidase deficiency (2)  ·  Peroxisomal Disorders (2)  ·  Refsum Disease, Infantile (2)  ·  Sphingolipidoses (2)  ·  Adrenoleukodystrophy (1)  ·  Aspartylglucosaminuria (1)  ·  Chondrodysplasia Punctata, Rhizomelic (1)  ·  Fucosidosis (1)  ·  Hereditary Diffuse Leukoencephalopathy with Spheroids (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Metabolism, Inborn Errors (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genetic Diseases, Inborn (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Kidney Diseases (3)  ·  Liver Diseases (3)  ·  Male Urogenital Diseases (3)

Interventions

Chenodeoxycholic Acid (1)  ·  Cholic Acid (1)  ·  Regimen B (1)  ·  Stem Cell Transplantation (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  University of Cincinnati (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Kenneth Setchell (1)  ·  Nancy E Braverman, MD, MS (1)  ·  Paul Orchard, M.D. (1)

Results publications

PMID 34534157, PMID 35106698, PMID 37541626